← Back
Pharmacology I · Exam 3 · Class of 2028

Tuberculosis Drugs Compared

The four first-line drugs and the second-line agents: whether each is bacteriostatic or bactericidal, what it targets, how it is used, its signature adverse effects, what to monitor and teach, and how it is eliminated or resisted. No doses.

Lecture 11 — Drugs for Pulmonary Infections, Asthma and Chronic Obstructive Pulmonary Disease 6 rows

One signature per drug. Isoniazid: peripheral neuritis, prevented by pyridoxine. Rifampin: orange secretions and enzyme induction (it lowers contraceptives and anticoagulants). Ethambutol: red-green color vision. Pyrazinamide: hyperuricemia and hepatitis, and not in pregnancy. Three of the four can inflame the liver (isoniazid, rifampin, pyrazinamide). Isoniazid and ethambutol both act on the waxy mycolic acid coat; rifampin acts on RNA polymerase. The slides disagree with standard microbiology on one point: rifampin’s spectrum list puts Neisseria and Legionella among gram-positive organisms; both are gram-negative, and the list is not used here. Doses are not tested and are left out.
DrugStatic or cidalMechanismUseKey adverse effectsMonitoring and educationElimination and resistanceSource
The regimen—Mycobacteria are acid-fast bacilli with a waxy mycolic acid coat; M. tuberculosis grows very slowly and can lie dormant, so drugs that act on cell division work less wellTwo months of isoniazid, rifampin, ethambutol and pyrazinamide, then four months of isoniazid and rifampin; pulmonary 6 to 9 months, with HIV (human immunodeficiency virus) 9 to 12, complicated 18 to 24—Never single agents in active diseaseIsoniazid or rifampin resistance: treat 18 to 24 monthsL11
slide 35
slide 34
slide 36
slide 46
IsoniazidBacteriostatic for latent, bactericidal for dividing bacteriaInhibits mycolic acid production (the waxy cell coat); activated by the bacterial catalase-peroxidaseProphylaxis alone; active disease in combinationPeripheral neuritis (pyridoxine deficiency); hepatitis (more in alcoholics and with age); lupus-like syndrome; seizures, euphoria, psychosis, memory impairmentGive pyridoxine (vitamin B6); liver tests, especially with alcohol use or older age75 to 95 percent excreted as an acetylated metabolite (fast and slow acetylators); well absorbed, enters the central nervous system; resistance by mutation in the activating enzyme’s geneL11
slide 37
slide 38
slide 39
slide 33
RifampinNot statedInhibits DNA-dependent RNA polymerase by forming a complex with the enzyme (no effect on the human enzyme); a semi-synthetic rifamycinTuberculosis; meningococcal disease prophylaxis; endocarditisOrange tears, sweat and urine; induces cytochrome P450 enzymes; jaundice, hepatitis; flu-like hypersensitivity (20 percent); gastrointestinal upsetWarn about the orange color; review interacting drugs (anticoagulants, contraceptives, digoxin, ketoconazole, theophylline)Rarely used alone: tolerance develops rapidlyL11
slide 41
slide 42
slide 40
slide 33
EthambutolBacteriostaticMechanism unknown: inhibits mycolic acid incorporation into membranes; no effect on other bacteria; the weakened cell wall lets the other agents inFirst two months of the four-drug startVisual disturbances: decreased red-green discrimination and visual acuity; increased uric acidAsk about vision and color perception75 percent excreted unchanged: adjust in renal disease; resistance develops quickly if used aloneL11
slide 43
slide 44
slide 33
PyrazinamideNot statedConverted to pyrazinoic acid, which lowers the pH so the bacteria cannot grow; enters macrophages; exact target unclearShortens the combined course; given in the first two months onlyHepatitis (15 percent); hyperuricemia in every patient (inhibits uric acid excretion)Monitor liver enzymes; avoid in pregnancyLimited to the first two months to avoid liver toxicityL11
slide 45
slide 33
Second-line agents——Resistance or drug intolerance: streptomycin, aminosalicylic acid, cycloserine, rifabutin, macrolides, quinolones, clofazimine (leprosy), linezolidStreptomycin auditory and vestibular; aminosalicylic acid gastrointestinal; cycloserine central nervous system (psychosis, seizures)Hearing and balance; stomach upset; mood and seizures—L11
slide 46